List view / Grid view
26 June 2019 | By Merck
Antibody-drug conjugates (ADC) represent a rapidly emerging class of biotherapeutic molecules, which harness the specificity of monoclonal antibodies (mAb) to selectively deliver highly potent cytotoxic drugs. Like all biotherapeutics they require significant analytical characterization.
25 June 2019 | By European Pharmaceutical Review
The latest research and developments from Pharma and Biopharma industry experts.
24 June 2019 | By JRS Pharma
Spray-dried lactose is widely used as a filler and binder in the pharmaceutical industry, but many adults are not able to digest lactose. Therefore, it is indispensable to provide alternatives to lactose-containing drugs in order to make them suitable for lactose intolerant patients.
20 June 2019 | By European Pharmaceutical Review
This in-depth focus looks into industrial workflow processes and also how nature can provide inspiration for drug delivery.
20 June 2019 | By James Mellman - Device Manager at Novartis
The increasing complexity of formulations and active biological products raises new challenges for pre-filled syringe development. James Mellman, Device Manager at Novartis, speaks to Nikki Withers about the challenges of selecting the right primary packaging for injectable formulations and how he has learnt to expect the unexpected.
20 June 2019 | By Victoria Rees (European Pharmaceutical Review)
Researchers have found that many pharmaceutical products contain inactive ingredients which can be dangerous to patients.
20 June 2019 | By European Pharmaceutical Review
In this issue we explore reasons behind critical key drug shortages in the EU, whether viability methods effectively detect all viable organisms and how companies can future-proof their digital technologies ahead of Brexit. Also included are articles on higher order protein structure, FMD compliance and Raman spectroscopy.
19 June 2019 | By Lonza
Comparative human in-vivo study of an immediate release tablet over-encapsulated by gelatin and hydroxypropyl methyl cellulose capsules –impact of dissolution rate on bioequivalence.
5 June 2019 | By JRS Pharma
Lubricants have a far more wide-reaching impact on the characteristics of the finished tablet than merely easing their means of production. A study was carried out to investigate precisely what those effects were.
16 May 2019 | By JRS Pharma
JRS Pharma present VIVAPUR MCG and outline the benefits of its formulation for application in nasal sprays.
13 May 2019 | By Christopher Fox, Dr Daniel Hoft
Vaccinations have begun in a phase I human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate. Nikki Withers speaks to Dr Daniel Hoft and Christopher Fox about the formulation process and what this means for vaccine development going forward.
10 May 2019 | By Eurofins
From starting materials through to finished product testing, Eurofins BioPharma Product Testing’s 34 facilities in 17 countries deliver a comprehensive scope of harmonised GMP testing services and seamless regulatory acceptance.
10 May 2019 | By Chemspec Europe 2019
Chemspec Europe 2019 gathers impressive array of industry experts under one roof
26 April 2019 | By European Pharmaceutical Review
As today’s scientists continue to identify new biopharmaceutical products with potential to treat a wide array of diseases, formulation remains the determining factor in their success. But what is involved in these increasingly complex formulation processes and how do they impact the packaging and delivery systems?
25 April 2019 | By European Pharmaceutical Review
This issue questions whether companies are sufficiently investing in regulatory intelligence software and what the potential consequences of Brexit might be for locations outside of the UK and EU. The issue also features articles on microbiology, formulation and biopharma, courtesy of our in-depth focus sections; as well as outlining the…
Follow: